Upgrade to SI Premium - Free Trial

Pfizer (PFE) Granted FDA Approval for SUTENT (sunitinib malate)

November 16, 2017 4:59 PM
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Next Articles